TEVAR is associated with promising long-term survival extended to 10 years, though rates of freedom from reintervention remain an ongoing point for improvement. Randomized controlled trials comparing endovascular with open repair in the setting of acute, complicated type B aortic dissection are needed.
No takes yet. Share an insight, caveat, or question.
Wilson‐Smith et al. (2021) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: